Daniela Bressanin

Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia

Carolina Simioni, Luca M. Neri, Giovanna Tabellini et al. · Leukemia · 2012 · 87 citations · Full text

Hematological Malignancy, Novel Akt Inhibitor, Medicine +8

Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: Eliminating activity by targeting at different levels

Daniela Bressanin, Camilla Evangelisti, Francesca Ricci et al. · Oncotarget · 2012 · 71 citations · Full text

Spermidine application to young developing peach fruits leads to a slowing down of ripening by impairing ripening‐related ethylene and auxin metabolism and signaling

Patrizia Torrigiani, Daniela Bressanin, Karina B. Ruiz et al. · Physiologia Plantarum · 2012 · 59 citations

Biology, Peach Fruits, Flesh Softening +14

A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia

Francesca Chiarini, Annalisa Lonetti, Gabriella Teti et al. · Oncotarget · 2012 · 58 citations · Full text

Activity of the selective IκB kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia

Francesca Buontempo, Francesca Chiarini, Daniela Bressanin et al. · Cell Cycle · 2012 · 42 citations · Full text

Hematological Malignancy, Cancer Research, Iκb Kinase +13